• No results found

Superficial Bladder Cancer.

Comparative study of BCG vs BCG + Interferon Combination as Intravesical Therapy in Superficial Bladder Cancer.

Comparative study of BCG vs BCG + Interferon Combination as Intravesical Therapy in Superficial Bladder Cancer.

... BCG is currently the most effective intravesical agent for the treatment and prophylaxis of superficial bladder cancer. BCG is recognized as a nonspecific immune stimulant. Intravesical BCG induces ...

77

Mechanism research of pirarubicin postoperative immediately bladder irrigation combined compound matrine injection on treating superficial bladder cancer

Mechanism research of pirarubicin postoperative immediately bladder irrigation combined compound matrine injection on treating superficial bladder cancer

... with superficial bladder cancer treated in our hospital from Jan2011 to Jun2016 were ...of bladder, 20 cases on side wall of bladder, 6 cases on floor of bladder, 12 cases on ...

5

Effect of oral administration of Shiquandabu pill combined with bladder perfusion chemotherapy on the postoperative recurrence and malignant degree of superficial bladder cancer

Effect of oral administration of Shiquandabu pill combined with bladder perfusion chemotherapy on the postoperative recurrence and malignant degree of superficial bladder cancer

... as cancer cell invasion and migration in bladder cancer tissue, and they can be secreted into the blood circulation by tumor lesions and then become the marker molecules reflecting tumor load [12-14] ...

5

A Study of Side Effects & Tolerability of Intravesical ‘BCG’ in Superficial Bladder Cancer.

A Study of Side Effects & Tolerability of Intravesical ‘BCG’ in Superficial Bladder Cancer.

... Although thorough endoscopic tumor resection remains the principal treatment, intravesical agents have become an important in the subgroup of tumors that are at risk of progression. Intravesical Bacillus Calmette-Guerin, ...

76

NMP22 is predictive of recurrence in high risk superficial bladder cancer patients

NMP22 is predictive of recurrence in high risk superficial bladder cancer patients

... Study participants did not know the results of the NMP22 assay until after all 100 consecutive patients had been enrolled. After complete enrolment, retrospective chart reviews were undertaken documenting events from the ...

5

Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence

Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence

... Patients were followed up every 3 months with urine cy- tology and cystoscopy during the first year, every 6 months for the next 2 years, and then yearly thereafter. Ultrasonog- raphy, CT scanning, cystoscopy and urinary ...

5

Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation

Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation

... Materials and methods: For this purpose, bioadhesive microspheres were successfully prepared with average particle size, encapsulation efficiency, and loading capacity of 98.4 µm, 82.657%±5.817%, and 12.501±0.881 mg, ...

17

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

... orthotopic bladder tumour ...in bladder cancer including endostatin (Shichinohe et al, 2001) and p53 (Ruifa et al, ...offer bladder tumour selective killing due to viral replication and even ...

12

INTRAVESICAL MISTLETOE EXTRACT FOR ADJUVANT TREATMENT OF SUPERFICIAL URINARY BLADDER CANCER

INTRAVESICAL MISTLETOE EXTRACT FOR ADJUVANT TREATMENT OF SUPERFICIAL URINARY BLADDER CANCER

... of superficial bladder cancer has been shown to decrease tumor recurrence from about 70 % to 30 % in several studies and therefore has become an established therapy for this tumor entity ...

7

Mathematical Modeling For The Tumor Growth In The Bladder

Mathematical Modeling For The Tumor Growth In The Bladder

... the bladder is lined with cells called transitional cells and squamous ...National Cancer Institute found that more than 90 percent of bladder cancers originate in the transitional ...of ...

6

Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Staging of Bladder Cancer

Click here to download PDF version of the article !

... to bladder wall, assisting in differentiating tumour from surrounding normal ...of bladder carcinoma and its correlation with pathologic findings and concluded that MRI showed detection of bladder ...

5

Original Article UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy

Original Article UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy

... of cancer cell lines and primary tumors, whereas only low levels have been found in nor- mal tissues ...in superficial bladder cancer patients who were treated with trans- urethral resection ...

8

C14orf166 is a high risk biomarker for bladder cancer and promotes bladder cancer cell proliferation

C14orf166 is a high risk biomarker for bladder cancer and promotes bladder cancer cell proliferation

... of bladder cancer; we defined a relative risk of ...of bladder cancer, and is an unfavorable prognostic factor for patients with bladder ...

10

Laser treatment of bladder cancer

Laser treatment of bladder cancer

... patient tolerance of PDT with these sensitisers and despite warnings, most series report a small number of patients who develop significant sunburn. Other ways of administering photosensitisers have been tried with the ...

393

P3H4 is correlated with clinicopathological features and prognosis in bladder cancer

P3H4 is correlated with clinicopathological features and prognosis in bladder cancer

... To further investigate the prognostic role of P3H4 in bladder cancer, we performed Kaplan–Meier and Cox regression analyses. Kaplan–Meier analysis showed that survival prognosis was different between the ...

6

Fuzzy Modelling for Predicting the Risk of Recurrence and Progression of Superficial Bladder Tumors

Fuzzy Modelling for Predicting the Risk of Recurrence and Progression of Superficial Bladder Tumors

... Nowadays, bladder cancer is the fourth most common cancer in adults and the second most frequent urogenital ...of superficial bladder tumors, with available clinical information to ...

13

Markers for Diagnosis and Progression in Bladder Cancer

Markers for Diagnosis and Progression in Bladder Cancer

... Bladder cancer is a common disease that is often detected late and has a high rate of recurrence and ...non-muscle-invasive bladder cancer, and predicting progression to muscle-invasive ...

5

Original Article Expression of TMEM40 in bladder cancer and its correlation with clinicopathological parameters

Original Article Expression of TMEM40 in bladder cancer and its correlation with clinicopathological parameters

... of bladder cancer has made great ...(the Cancer Genome Atlas, TCGA) revealed a study that contained outlined genome, transcriptome, mutational data and correlated many molecular events with specific ...

8

FGFR3 expression in primary invasive bladder cancers and matched lymph node metastases.

FGFR3 expression in primary invasive bladder cancers and matched lymph node metastases.

... advanced bladder cancer is not yet clear and awaits the results of early clinical ...muscle-invasive bladder cancer treated by cystectomy with or without adjuvant cisplatin-gemcitabine ...

17

Perioperative chemotherapy for bladder cancer: A qualitative study of physician knowledge, attitudes, and behaviour

Perioperative chemotherapy for bladder cancer: A qualitative study of physician knowledge, attitudes, and behaviour

... of bladder cancer treatment (skills), lack of confidence that the survival benefit of NACT/ACT is clinically important (beliefs about consequences), lack of urology presence at multidisciplinary case ...

19

Show all 10000 documents...

Related subjects